Odanacatib, a selective cathepsin k inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women.
- Resource Type
- Journal Article
- Source
- Journal of Clinical Endocrinology & Metabolism; 2014 Feb, Vol. 99 Issue 2, p552-560, 9p
- Subject
- Language
- ISSN
- 0021972X